By Tom Fox2015-10-14T09:30:00
Image: The Schrems decision last week invalidated the safe harbor provision that let U.S. companies ferry personal data back and forth from Europe. Already compliance officers are beginning to sweat the implications of that ruling for anti-corruption programs. First likely headache: hotline data. Tom Fox, our Man From FCPA, has ...
2025-12-05T21:00:00Z By Pekka Alasaari and Johanna Schüßler, CW guest columnists
The European manufacturing industry is on the cusp of a regulatory shift that promises to reshape how machines are designed and operated.
2025-12-04T22:15:00Z By Ruth Prickett
Regulation is a matter of life and death in the pharmaceutical industry. Rules to combat practices that can kill have been in force for decades, but tech developments are rapidly creating new risks and focusing lawmakers’ attention on areas where some compliance teams may lack experience.
2025-11-24T21:19:00Z By Jaclyn Jaeger
Since the start of the Trump Administration, the Department of Justice has been winding down a number of Foreign Corrupt Practices Act investigations with little public attention. This second article further explores how and why these FCPA matters have been closed.
Site powered by Webvision Cloud